Oral-health probiotic strain BLIS M18 gets FDA No Objection GRAS letter
BLIS M18 is the second oral-health probiotic strain from Blis Technologies and its North American distributor Stratum Nutrition.
Photo © iStockphoto.com/Kurhan
BLIS M18, the second oral-health probiotic strain from Blis Technologies (Dunedin, NZ) and its North American distributor Stratum Nutrition (Carthage, MO), has received a “Letter of No Objection” from the U.S. FDA in responses to a filing for Generally Recognized as Safe (GRAS) status.
Blis Technologies previously received a Letter of No Objection GRAS response for its first, well-known oral-health probiotic strain BLIS K12. Said the companies in a press release: “GRAS status adds a new level of credibility for BLIS M18 and has the potential to open up opportunities with larger consumer food and beverage companies in the U.S., but also is recognized as a relevant and credible safety assessment by other countries and multinational companies.”
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
